These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23679812)

  • 1. Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Kawakita D; Masui T; Hanai N; Ozawa T; Hirakawa H; Terada A; Nishio M; Hosoi H; Hasegawa Y
    Acta Otolaryngol; 2013 May; 133(5):523-30. PubMed ID: 23679812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
    Kim SY; Roh JL; Kim MR; Kim JS; Choi SH; Nam SY; Lee SW; Kim SB
    J Nucl Med; 2007 May; 48(5):752-7. PubMed ID: 17475963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
    Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma.
    Makino T; Miyata H; Yamasaki M; Fujiwara Y; Takiguchi S; Nakajima K; Higuchi I; Hatazawa J; Mori M; Doki Y
    Surgery; 2010 Nov; 148(5):908-18. PubMed ID: 20378140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between extracapsular spread and FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
    Acta Otolaryngol; 2013 Oct; 133(10):1073-9. PubMed ID: 24032571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
    Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
    PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
    Oh JS; Kang BC; Roh JL; Kim JS; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Aug; 22(8):2746-54. PubMed ID: 25487968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma.
    Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Maruo T; Naganawa S; Hasegawa Y; Nakashima T
    Ann Nucl Med; 2013 Apr; 27(3):297-302. PubMed ID: 23337965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
    Zaizen Y; Azuma K; Kurata S; Sadashima E; Hattori S; Sasada T; Imamura Y; Kaida H; Kawahara A; Kinoshita T; Ishibashi M; Hoshino T
    Eur J Radiol; 2012 Dec; 81(12):4179-84. PubMed ID: 22884163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes.
    Lee HY; Lee KS; Park J; Han J; Kim BT; Kwon OJ; Ahn YC; Ahn MJ; Park K; Kim J; Shim YM
    Acad Radiol; 2012 Apr; 19(4):440-5. PubMed ID: 22265854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Ng SH; Lin CY; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Huang SF; Lin YC; Wang JJ
    PLoS One; 2013; 8(8):e72230. PubMed ID: 23951300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
    Kim MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Surg Oncol; 2007 Jun; 33(5):633-8. PubMed ID: 17391904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.
    Nakaminato S; Toriihara A; Makino T; Kawano T; Kishimoto S; Shibuya H
    Acta Oncol; 2012 May; 51(5):645-52. PubMed ID: 22229748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
    Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.
    Ng SH; Chan SC; Liao CT; Chang JT; Ko SF; Wang HM; Chin SC; Lin CY; Huang SF; Yen TC
    Neuroradiology; 2008 Nov; 50(11):969-79. PubMed ID: 18600319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.
    Huang YT; Ravi Kumar AS; Bhuta S
    Nucl Med Commun; 2015 Jan; 36(1):16-20. PubMed ID: 25340950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [((18)F)-fluorodeoxyglucose PET/CT in cervix cancer: lymph node assessment and prognostic/predictive value of primary tumour analysis].
    Leseur J; Devillers A; Williaume D; Le Prisé E; Fougerou C; Bouriel C; Levêque J; Monpetit E; Blanchot J; de Crevoisier R; Garin E
    Cancer Radiother; 2011 Dec; 15(8):699-708. PubMed ID: 22104953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
    Kim MJ; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2013 Mar; 20(3):899-905. PubMed ID: 23161114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serial (18)F-FDG PET-CT imaging during radiotherapy for nasopharyngeal carcinoma: a prospective clinical study].
    Lin Q; Yang RS; Sun L; Li YM; Wang LC; Dai MM; Luo ZM; Zhao L; Wu H
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):356-9. PubMed ID: 22883456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET-CT scan-based maximum standardized uptake value as a prognostic predictor in oropharynx squamous cell cancer.
    Patel Y; Srivastava S; Rana D; Goel A; Suryanarayana K; Saini SK
    Cancer Treat Res Commun; 2021; 26():100305. PubMed ID: 33461080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.